Summary
Andrew Closson is a product leader and PhD-trained bioengineer with nine years of experience building and commercializing digital health and medical device products from concept through clinical validation. Currently Director of Product at Lazarus AI and consulting for Attuned HealthTech, he blends hands-on technical expertise in flexible materials and sensors with product strategy, regulatory navigation, and go-to-market execution. He co-founded PulseFlex, where he scaled a multidisciplinary team, secured funding, and led IRB-approved clinical testing for a wearable sensor MVP. Known for translating complex engineering and thermodynamics into usable products, he has also driven grant-funded research, authored numerous papers, and helped win a $250K NIH award. Based in Greater Boston, he uniquely combines academic rigor with startup execution to move biomedical innovations toward real-world impact.
9 years of coding experience
7 years of employment as a software developer
Bachelor of Science (BS) Bioengineering and Biomedical Engineering, Bachelor of Science (BS) Bioengineering and Biomedical Engineering at University of Maine
Doctor of Philosophy - PhD Bioengineering and Biomedical Engineering, Doctor of Philosophy - PhD Bioengineering and Biomedical Engineering at Thayer School of Engineering at Dartmouth